CD274 and neoplasm: Tessier-Cloutier et al. used immunohistochemistry (IHC) to examine the prevalence of PD-L1 expression in pancreatic ductal adenocarcinoma and compared it with clinical characteristics, including MMR status and tumor-infiltrating lymphocytes (TILs), to determine if there was a correlation with clinical outcomes.